Edges in Network
| Network | GSE25065_top8000 - GSE25065 - SiGN-BN NNSR |
| Network Description | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | EIF2AK3 |
| Upstream (Parents) |
|---|
| (<<) CDC73 → EIF2AK3 |
| (<<) RPS11 → EIF2AK3 |
| (<<) SEC22B → EIF2AK3 |
| Downstream (Children) |
|---|
| EIF2AK3 → TMOD3 (>>) |
| EIF2AK3 → TMEM135 (>>) |
| EIF2AK3 → CLCN3 (>>) |
| EIF2AK3 → MBNL2 (>>) |
| EIF2AK3 → RFPL1S (>>) |
| EIF2AK3 → THAP1 (>>) |
| EIF2AK3 → F11R (>>) |
| EIF2AK3 → C6orf54 (>>) |
| EIF2AK3 → PGM3 (>>) |
| EIF2AK3 → GRIK5 (>>) |
| EIF2AK3 → SCN3A (>>) |
| EIF2AK3 → SLC33A1 (>>) |
| EIF2AK3 → CDC73 (>>) |
| EIF2AK3 → LIN7C (>>) |
| EIF2AK3 → FCGR1A (>>) |
| EIF2AK3 → PDS5A (>>) |
| EIF2AK3 → NCOA1 (>>) |
| EIF2AK3 → NR6A1 (>>) |
| EIF2AK3 → PCYOX1 (>>) |
| EIF2AK3 → PRR7 (>>) |
| EIF2AK3 → EDEM3 (>>) |
| EIF2AK3 → TMSB4Y (>>) |
| EIF2AK3 → AP1G1 (>>) |
| EIF2AK3 → P2RX2 (>>) |
| EIF2AK3 → TRADD (>>) |
| EIF2AK3 → COMT (>>) |
| EIF2AK3 → SHANK1 (>>) |
| EIF2AK3 → MAGT1 (>>) |
| EIF2AK3 → PRRG3 (>>) |
| EIF2AK3 → NPHS1 (>>) |
| EIF2AK3 → AVP (>>) |
| EIF2AK3 → SRP72 (>>) |
| EIF2AK3 → CELA2B (>>) |
| EIF2AK3 → CD164 (>>) |
| EIF2AK3 → NRL (>>) |
| EIF2AK3 → CDKL5 (>>) |
| EIF2AK3 → CITED2 (>>) |
| EIF2AK3 → RDH11 (>>) |
| EIF2AK3 → SLCO5A1 (>>) |
| EIF2AK3 → PAX5 (>>) |
| EIF2AK3 → NKX3-2 (>>) |
| EIF2AK3 → RANBP2 (>>) |
| EIF2AK3 → KIFC3 (>>) |
| EIF2AK3 → SIGLEC9 (>>) |
| EIF2AK3 → PLA2G1B (>>) |
| EIF2AK3 → MRPS18B (>>) |
| EIF2AK3 → SEC22B (>>) |
| EIF2AK3 → USO1 (>>) |
| EIF2AK3 → ACSL3 (>>) |
| EIF2AK3 → ALPK1 (>>) |
| EIF2AK3 → C14orf147 (>>) |
